skip to main content

Our response to the Covid-19 outbreak.

Research Library

Domestic Health Policy

Center for Health and Biosciences

Cancer Drugs in the United States: Justum Pretium — The Just Price

Hagop M. Kantarjian, M.D.

Cancer Drugs in the United States: Justum Pretium — The Just Price.

Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life. Published in the Journal of Clinical Oncology, October 2013.

By Hagop M. Kantarjian, Baker Institute scholar in health policy; Tito Fojo, National Cancer Institute, National Institutes of Health; Michael Mathisen, MD Anderson Cancer Center; and Leonard A. Zwelling, MD Anderson Cancer Center

Click here to read the full article.